Teligent, Inc. is a topical and injectable pharmaceutical company that markets a growing portfolio of FDA-approved medicines, including several generic alternatives, in the United States. This includes injectable and topical prescription medicines.

Teligent, Inc.

Teligent Communicator

Domain Not Resolving

COVID-19

Gravity Forms

403 Error

WPML Multilingual

Bhaskar Chaudhuri

James C. Gale

Joyce Erony

Narendra N. Borkar

Michael Hemric

Ernest R. De Paolantonio

CFO Teligent Inc.

Timothy Sawyer

Chief Executive Officer & President

Steve Richardson

Chief Scientific Officer

New Jersey Public Companies With More Than $10M in Revenue

Marketing Public Companies With More Than 10 Employees

Pharmaceutical Public Companies With More Than 10 Employees

Pharmaceutical Companies With Fewer Than 100 Employees (Top 10K)

Teligent develop, manufacture and market pharmaceutical products for use by doctors and patients in the United States and Canada.

They are a dynamic group of about 130 employees based in New Jersey, Toronto, Montreal and Tallinn, Estonia. Their Product Development and Manufacturing complex is in Buena, New Jersey, approximately 45 minutes from Philadelphia. In 2015 They acquired Alveda Pharmaceuticals Inc., a Toronto-based pharmaceutical company focused on the Canadian injectable pharmaceutical market. In 2016 They hired Their first European colleagues in Tallinn who support Their supply chain and quality operations.

Post-IPO Equity - Teligent

Buena

New Jersey

United States

North America

Teligent

Teligent seeks to convert bankruptcy to Chapter 7 amid impasse with creditors

PAI further bolsters its portfolio with the acquisition of Teligent Sterile Injectable and Topical products

Hikma shells out $45.75M to buy bankrupt Teligent's Canadian assets

Hikma expands into Canada with acquisition of Teligent sterile injectable assets

Teligent, Edge Pharma yank meds on superpotency, sterility concerns

Plaintiffs Want Teligent Price-Fixing Lawsuit to Continue Despite Bankruptcy

Generic drugmaker Teligent approved to tap bankruptcy loan

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

Exelixis, Storm join up in collaboration and license agreement; Teligent files for bankruptcy

Generic drugmaker Teligent files for Chapter 11, plans sale

HTML5

Vimeo

Starfield SSL

jQuery

Google Maps API

Google Fonts

F5 NGINX

GoDaddy

Amazon EC2

Modernizr

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 29, 2024 11:04 AM	5422b271
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 29, 2024 11:04 AM	fd5110be
crunchbase trigger	general	Nov 12, 2024 12:52 PM	44444ea7
crunchbase profile	general	Nov 12, 2024 1:24 PM	3e61c390
li profile	general
translate crunchbase fundingrounds	general	Nov 12, 2024 1:51 PM	49e3edcd
peers	general	Sep 29, 2024 11:04 AM	f16a5b55
news basic	general	Sep 29, 2024 11:04 AM	a91e62be
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

TLGT

COM:TELIGENT

Teligent, Inc.

Last Close

0.20

01/01 00:00

Volume Today

72.25M

Avg: -